Back
Sarepta Therapeutics Vs. Digimarc Industry Stock Comparison
Sell
50
SRPT
Sarepta Therapeutics
Last Price:
$124.44
Seasonality Move:
9.24%
Buy
69
DMRC
Digimarc
Last Price:
$47.29
Seasonality Move:
-0.46%
Sell
50
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $127.89. The Score for SRPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $127.89The current trend is moderately bullish and SRPT is experiencing slight buying pressure.
DMRC Stock Price Chart
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.49 | Buy |
Relative Strength Index (14 RSI): | 59.07 | Buy |
Chaikin Money Flow: | 219146 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (121.31 - 128.07) | Buy |
Bollinger Bands (100): | (117.93 - 133.49) | Buy |
DMRC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.6 | Buy |
Relative Strength Index (14 RSI): | 78.22 | Buy |
Chaikin Money Flow: | 85595 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.95 - 40.57) | Buy |
Bollinger Bands (100): | (27.05 - 35.65) | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 123.48 | Buy |
20-day SMA: | 123.86 | Buy |
50-day SMA: | 122.48 | Buy |
200-day SMA: | 129.66 | Sell |
8-day EMA: | 124.26 | Buy |
20-day EMA: | 123.47 | Buy |
50-day EMA: | 123.6 | Buy |
200-day EMA: | 125.76 | Buy |
DMRC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.59 | Buy |
20-day SMA: | 37.98 | Buy |
50-day SMA: | 34.59 | Buy |
200-day SMA: | 29.38 | Buy |
8-day EMA: | 41.69 | Buy |
20-day EMA: | 38.66 | Buy |
50-day EMA: | 35.39 | Buy |
200-day EMA: | 31.4 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.84 per share, and an increase next year of $4.82 per share.
Digimarc Earnings Growth & DMRC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Digimarc Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |